@ARTICLE{Parisi2022,
	author = {Parisi, Sarah and Ruggeri, Loredana and Dan, Elisa and Rizzi, Simonetta and Sinigaglia, Barbara and Ocadlikova, Darina and Bontadini, Andrea and Giudice, Valeria and Urbani, Elena and Ciardelli, Sara and Sartor, Chiara and Cristiano, Gianluca and Nanni, Jacopo and Zannoni, Letizia and Chirumbolo, Gabriella and Arpinati, Mario and Lewis, Russell E. and Bonifazi, Francesca and Marconi, Giovanni and Martinelli, Giovanni and Papayannidis, Cristina and Paolini, Stefania and Velardi, Andrea and Cavo, Michele and Lemoli, Roberto M. and Curti, Antonio},
	title = {Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters},
	year = {2022},
	journal = {Frontiers in Immunology},
	volume = {12},
	doi = {10.3389/fimmu.2021.804988},
	url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85124594156&doi=10.3389%2ffimmu.2021.804988&partnerID=40&md5=8c0329ab06e2b2d01a3df7408a26e749},
	type = {Article},
	publication_stage = {Final},
	source = {Scopus},
	note = {Cited by: 8; All Open Access, Gold Open Access, Green Open Access}
}

{"_id":"dLzM4evKdsmJDLtd4","bibbaseid":"parisi-ruggeri-dan-rizzi-sinigaglia-ocadlikova-bontadini-giudice-etal-longtermoutcomeafteradoptiveimmunotherapywithnaturalkillercellsalloreactivenkcelldosestillmatters-2022","author_short":["Parisi, S.","Ruggeri, L.","Dan, E.","Rizzi, S.","Sinigaglia, B.","Ocadlikova, D.","Bontadini, A.","Giudice, V.","Urbani, E.","Ciardelli, S.","Sartor, C.","Cristiano, G.","Nanni, J.","Zannoni, L.","Chirumbolo, G.","Arpinati, M.","Lewis, R. E.","Bonifazi, F.","Marconi, G.","Martinelli, G.","Papayannidis, C.","Paolini, S.","Velardi, A.","Cavo, M.","Lemoli, R. M.","Curti, A."],"bibdata":{"bibtype":"article","type":"Article","author":[{"propositions":[],"lastnames":["Parisi"],"firstnames":["Sarah"],"suffixes":[]},{"propositions":[],"lastnames":["Ruggeri"],"firstnames":["Loredana"],"suffixes":[]},{"propositions":[],"lastnames":["Dan"],"firstnames":["Elisa"],"suffixes":[]},{"propositions":[],"lastnames":["Rizzi"],"firstnames":["Simonetta"],"suffixes":[]},{"propositions":[],"lastnames":["Sinigaglia"],"firstnames":["Barbara"],"suffixes":[]},{"propositions":[],"lastnames":["Ocadlikova"],"firstnames":["Darina"],"suffixes":[]},{"propositions":[],"lastnames":["Bontadini"],"firstnames":["Andrea"],"suffixes":[]},{"propositions":[],"lastnames":["Giudice"],"firstnames":["Valeria"],"suffixes":[]},{"propositions":[],"lastnames":["Urbani"],"firstnames":["Elena"],"suffixes":[]},{"propositions":[],"lastnames":["Ciardelli"],"firstnames":["Sara"],"suffixes":[]},{"propositions":[],"lastnames":["Sartor"],"firstnames":["Chiara"],"suffixes":[]},{"propositions":[],"lastnames":["Cristiano"],"firstnames":["Gianluca"],"suffixes":[]},{"propositions":[],"lastnames":["Nanni"],"firstnames":["Jacopo"],"suffixes":[]},{"propositions":[],"lastnames":["Zannoni"],"firstnames":["Letizia"],"suffixes":[]},{"propositions":[],"lastnames":["Chirumbolo"],"firstnames":["Gabriella"],"suffixes":[]},{"propositions":[],"lastnames":["Arpinati"],"firstnames":["Mario"],"suffixes":[]},{"propositions":[],"lastnames":["Lewis"],"firstnames":["Russell","E."],"suffixes":[]},{"propositions":[],"lastnames":["Bonifazi"],"firstnames":["Francesca"],"suffixes":[]},{"propositions":[],"lastnames":["Marconi"],"firstnames":["Giovanni"],"suffixes":[]},{"propositions":[],"lastnames":["Martinelli"],"firstnames":["Giovanni"],"suffixes":[]},{"propositions":[],"lastnames":["Papayannidis"],"firstnames":["Cristina"],"suffixes":[]},{"propositions":[],"lastnames":["Paolini"],"firstnames":["Stefania"],"suffixes":[]},{"propositions":[],"lastnames":["Velardi"],"firstnames":["Andrea"],"suffixes":[]},{"propositions":[],"lastnames":["Cavo"],"firstnames":["Michele"],"suffixes":[]},{"propositions":[],"lastnames":["Lemoli"],"firstnames":["Roberto","M."],"suffixes":[]},{"propositions":[],"lastnames":["Curti"],"firstnames":["Antonio"],"suffixes":[]}],"title":"Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters","year":"2022","journal":"Frontiers in Immunology","volume":"12","doi":"10.3389/fimmu.2021.804988","url":"https://www.scopus.com/inward/record.uri?eid=2-s2.0-85124594156&doi=10.3389%2ffimmu.2021.804988&partnerID=40&md5=8c0329ab06e2b2d01a3df7408a26e749","publication_stage":"Final","source":"Scopus","note":"Cited by: 8; All Open Access, Gold Open Access, Green Open Access","bibtex":"@ARTICLE{Parisi2022,\n\tauthor = {Parisi, Sarah and Ruggeri, Loredana and Dan, Elisa and Rizzi, Simonetta and Sinigaglia, Barbara and Ocadlikova, Darina and Bontadini, Andrea and Giudice, Valeria and Urbani, Elena and Ciardelli, Sara and Sartor, Chiara and Cristiano, Gianluca and Nanni, Jacopo and Zannoni, Letizia and Chirumbolo, Gabriella and Arpinati, Mario and Lewis, Russell E. and Bonifazi, Francesca and Marconi, Giovanni and Martinelli, Giovanni and Papayannidis, Cristina and Paolini, Stefania and Velardi, Andrea and Cavo, Michele and Lemoli, Roberto M. and Curti, Antonio},\n\ttitle = {Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters},\n\tyear = {2022},\n\tjournal = {Frontiers in Immunology},\n\tvolume = {12},\n\tdoi = {10.3389/fimmu.2021.804988},\n\turl = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85124594156&doi=10.3389%2ffimmu.2021.804988&partnerID=40&md5=8c0329ab06e2b2d01a3df7408a26e749},\n\ttype = {Article},\n\tpublication_stage = {Final},\n\tsource = {Scopus},\n\tnote = {Cited by: 8; All Open Access, Gold Open Access, Green Open Access}\n}\n\n","author_short":["Parisi, S.","Ruggeri, L.","Dan, E.","Rizzi, S.","Sinigaglia, B.","Ocadlikova, D.","Bontadini, A.","Giudice, V.","Urbani, E.","Ciardelli, S.","Sartor, C.","Cristiano, G.","Nanni, J.","Zannoni, L.","Chirumbolo, G.","Arpinati, M.","Lewis, R. E.","Bonifazi, F.","Marconi, G.","Martinelli, G.","Papayannidis, C.","Paolini, S.","Velardi, A.","Cavo, M.","Lemoli, R. M.","Curti, A."],"key":"Parisi2022","id":"Parisi2022","bibbaseid":"parisi-ruggeri-dan-rizzi-sinigaglia-ocadlikova-bontadini-giudice-etal-longtermoutcomeafteradoptiveimmunotherapywithnaturalkillercellsalloreactivenkcelldosestillmatters-2022","role":"author","urls":{"Paper":"https://www.scopus.com/inward/record.uri?eid=2-s2.0-85124594156&doi=10.3389%2ffimmu.2021.804988&partnerID=40&md5=8c0329ab06e2b2d01a3df7408a26e749"},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/f/z9HzMuFfTZBTCahC4/scopus.bib","dataSources":["jKN7prtxaY9N8vqst","qLqjc4bwMYLmk2F3c","8E62bsJiEchQrmW6z","NcXuTqLcAyFRTYR5S","Q7T46e3zk4SYE595H"],"keywords":[],"search_terms":["long","term","outcome","adoptive","immunotherapy","natural","killer","cells","alloreactive","cell","dose","still","matters","parisi","ruggeri","dan","rizzi","sinigaglia","ocadlikova","bontadini","giudice","urbani","ciardelli","sartor","cristiano","nanni","zannoni","chirumbolo","arpinati","lewis","bonifazi","marconi","martinelli","papayannidis","paolini","velardi","cavo","lemoli","curti"],"title":"Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters","year":2022}